Acute Effects of an Oral Fat Load on Skeletal Muscle and Hepatic Insulin Sensitivity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-03-31

Study Completion Date

2022-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The development of type 2 diabetes is based on a combination of insulin resistance and beta cell dysfunction. In the last years, elevated FFA were recognized as a key players in the pathogenesis of insulin resistance and type 2 diabetes.

The study compares the acute effects of an oral lipid bolus on insulin sensitivity and hepatic glucose metabolism in healthy humans.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Free Fatty Acid Induced Insulin Resistance

NCT01229059

Insulin Resistance

COMPLETED

Lipids and Insulin Sensitivity

NCT01466816

Obesity Insulin Resistance

COMPLETED NA

Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity

NCT00523562

Metabolic Syndrome X Liver Diseases

COMPLETED NA

Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)

NCT02808182

Impaired Glucose Tolerance

COMPLETED NA

Substrate Cycling in Energy Metabolism

NCT00361751

Burns Insulin Resistance

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A dysregulation of lipid metabolism with increased levels of free fatty acids (FFA) represents one key mechanism in the pathogenesis of insulin resistance, which contributes to the development of type 2 diabetes (T2D). In most cases, dyslipidemia is related to obesity and the metabolic syndrome. Not only skeletal muscle glucose uptake, but also hepatic glucose fluxes are altered in insulin resistant states. In obese and T2D subjects, rates of gluconeogenesis (GNG) are increased, but in obese normoglycemic subjects endogenous glucose production (EGP) remains constant because of downregulation of glycogenolysis (GL). However, in T2D subjects, both GNG and GL are elevated, contributing to fasting and postprandial hyperglycemia. Therefore, elevated GNG rates may represent an early event in the pathophysiology of insulin resistance and T2D.

Preliminary studies of our institute show that intravenous lipid infusion with subsequent elevation of FFA results in increased GNG rates without alteration of EGP in lean, non-diabetic subjects. In another recent study we investigated the effects of an oral fat load on hepatic insulin sensitivity. As expected, we did not find any alterations in EGP; however, rates of GNG and GL have not been assessed.

The aim of this study is to analyze the effects of an oral fat load with transiently elevated levels of circulating lipids on hepatic glucose fluxes, especially GNG and GL, to elucidate the role of dietary fat in the induction of insulin resistance in healthy humans.

In this randomized, controlled cross-over study, effects of oral palm oil and canola oil ingestion will be investigated in young, healthy lean subjects. Hepatic glucose fluxes will be assessed by two independent methods, in vivo magnet resonance spectroscopy (MRS) and the deuterated water/acetaminophen method, which also allows for the determination of glycogen cycling rates. Furthermore, hepatic phosphorus metabolites and liver fat content will be monitored by MRS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Insulin Sensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Palm oil orally

oral fat load

Group Type ACTIVE_COMPARATOR

fat orally

Intervention Type BIOLOGICAL

Oral ingestion of palm oil or canola oil or water at timepoint zero

Canola oil orally

Oral fat load

Group Type ACTIVE_COMPARATOR

fat orally

Intervention Type BIOLOGICAL

Oral ingestion of palm oil or canola oil or water at timepoint zero

Water orally

oral water administration as control

Group Type PLACEBO_COMPARATOR

fat orally

Intervention Type BIOLOGICAL

Oral ingestion of palm oil or canola oil or water at timepoint zero

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

fat orally

Oral ingestion of palm oil or canola oil or water at timepoint zero

Intervention Type BIOLOGICAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

water orally

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy male and female subjects
* age 20-40
* BMI 20-25 kg/m2

Exclusion Criteria

* hyperlipidemia
* smoking
* pregnancy
* allergy against paracetamol/palm oil/canola oil
* contraindication for MRI investigations
* anaemia
* taking drugs influencing lipid or glucose metabolism, the immune system or antihypertensive treatment
* M. Meulengracht
* Hepatitis/HIV
* chronic diseases

Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes